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Allele Diversity of the H-ras1 Variable Number
of Tandem Repeats in Norwegian Lung Cancer
Patients
by David Ryberg,1 Toril Tefre,2 Vidar Skaug,1 Lodve
Stangeland,3 Steinar Ovreb0,1 Anne Naalsund,4 Anne-
Lise Borresen, and Aage Haugen1
We have examined restriction fragment length polymorphisms ofthe H-ras-1 gene in germ-line DNA from
214 lung cancer patients and 309 unaffected controls. When DNA samples were digested with MspIIHpaII,
Southernblotanalysisrevealed atleast22 differentalleles,groupedaccordingtotheirfrequencies ascommon,
intermediate, and rare. The frequency ofrare alleles in lungcancer patients (16/428) is significantly different
(p = 0.002) from that in the control group (5/618). Individuals with rare alleles were found to be at 4.7-fold
greater risk oflung cancer than those with no rare alleles.
Introduction
TheH-rasl geneisassociatedwithrestrictionfragment
length polymorphism (RFLP) resulting from a variable
number oftandem repeats (VNTR) of a 28-bp consensus
sequence in the 3'-flanking region. Several studies have
focused on this allelic variation in the search for genetic
markers of cancer susceptibility. RFLP studies by Kron-
tiris et al. (1) demonstrated a significantly higher fre-
quency of rare H-ras alleles in a mixed group of cancer
patients than among the controls. Several investigators
have failed to reproduce this observation for specific can-
certypes (2,3). Statistical analysis ofsome ofthese studies
has supported the suggestion that the reported associa-
tion between rare H-ras alleles and cancer susceptibility
may have occurred by chance (4). Furthermore, the
hypothesized relationship does not yet have a mechanistic
basis. In a previous RFLP study of the H-ras gene in
germ-line DNA from 118 lung cancer patients and 123
unaffected controls, we reported a significantly higher
frequency of rare alleles in the lung cancer group (2).
These results are in agreement with the finding of
Sugimura et al. (3) among U.S. lung cancerpatients. Inthe
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present study, we have extended the groups to comprise
214 cancer patients and 309 controls.
Materials and Methods
The lung cancer group comprised 214 patients of Nor-
wegian origin with untreated primary lung carcinomas.
The control group consisted of 309 healthy individuals
living in eastern and central Norway, all of Norwegian
origin. The groups were not matched with respect to
smoking habit or age.
DNA extraction and Southern blot analysis were per-
formed essentially as described previously (2). The chi-
square testwithYates'correctionwasusedforthe statisti-
cal analysis.
Results
We investigated the MspI/HpaII polymorphism ofthe
VNTR region flanking the H-rasl locus (Table 1) and
found at least 22 different alleles. They were grouped as
common, intermediate, and rare according to their fre-
quencies in the control group and criteria used by Kron-
tiris et al. (1). The incidence of rare alleles in the lung
cancer group (16/428) is significantly greater (p = 0.002)
thanthatin controls (5/618) (oddsratio = 4.76; 95% confi-
dence interval, 1.65-16.7). Disregarding the grouping,
there is apronounced scattering ofalleles on many differ-
ent fragment lengths in the lung cancer group. The small
variation in the fragment lengths ofalleles typed as 2.08-
kband2.57-kbalsoseemedtobemorefrequentinthelung
cancer group than in controls; however, this small varia-188 RYBERG ET AL.
Table 1. Comparison ofH-ras-1 alleles in lung cancer patients and
in unaffected controls.
Allele, Lungcancercases Controls
kb No. % No. % p-Value
1.00 257 60.0 416 67.3
1.45 47 11.0 63 10.2
2.08a 61 14.3 58 9.4
2.57a 20 4.7 52 8.4
Total common 385 90.0 589 95.3 0.01
(df=3)
0.97 5 1.2 5 0.8
1.03 6 1.4 5 0.8
1.06 4 0.9 6 1.0
1.11 10 2.3 4 0.6
1.42 2 0.5 4 0.6
Total intermediate 27 6.3 24 3.9 NS
1.09 - 1 0.2
1.17 2 0.5 -
1.36 1 0.2 1 0.2
1.48 2 0.5 -
1.50 3 0.7 1 0.2
1.57 1 0.2 -
1.71 1 0.2 -
1.80 1 0.2 -
1.83 1 0.2 -
2.37 - 1 0.2
2.51 2 0.2 1 0.2
2.96 1 0.2 -
3.05 1 0.2 -
Total rare 16 3.7 5 0.8 0.002
(df=1)
Abbreviations: NS, not significant; df, degrees offreedom.
aIncludes alleles thatmaydeviatebyabout 1 tandemrepeatunit(28bp)
from the indicated fragment length.
tion ofabout one tandem repeat unit (28 bp) is close to the
resolution limitofoursystem. Theexactsizeofthese allele
types is uncertain. Using a second restriction enzyme
endonuclease (AvaII), which detects the same polymor-
phism of the ras-VNTR region as MspI/HpaII, we have
excluded the existence of rare or intermediate alleles
resulting from restriction site polymorphisms.
Discussion
In this RFLP study of the VNTR region flanking the
H-rasl gene, we have demonstrated significantly in-
creased incidence of rare alleles among lung cancer
patients compared to unaffected controls. Comprising 214
patients and 309 controls, this study is so far the largest
performed on lung cancer. Our results confirm those ofa
similarstudybySugimuraetal. (3)ofwhiteandblacklung
cancerpatientsintheUnited States.Thefrequencyofrare
alleles in Norwegian and U.S. populations seems to be
different, in both the lung cancer and control groups;
however, the relative risk for lung cancer associated with
rareallelesissimilar(- 4).
Generally, theallelicvariability ofVNTRlocimaydiffer
widely from one locus to another. These differences are
probably associated with different mutation rates to new
alleles ofdifferentlengths (5). Thepronounceddiversityof
H-ras VNTR alleles in the lung cancer group that we
studied maythus reflectincreased instability ofthis locus
in this subpopulation. Our hypothesis is that a suscep-
tibility gene(s) is involved in the instability of the ras
VNTRregion. Thispredictsthatthesusceptibilitygene(s)
may segregate differently from the mutated VNTR allele.
Thus, only the newly originated (mutated) VNTR alleles
may be reliable markers for susceptibility, whether they
are classified as rare, intermediate, or common alleles in
the population, although these new mutations are statis-
tically most often found in the group ofrare alleles.
With regard to the mechanisms for generating new
VNTR alleles at the H-ras locus, unequal cross-over dur-
ingmeiotic recombination seems to be excluded (6). There
is some evidence that the rare alleles are most often
generated from the common allele of nearest fragment
length (6). Thus,themajorityofrarealleles havefragment
lengths scattered near those of the most common alleles.
A number ofcase-control studies have failed to demon-
strate any association between rare H-ras alleles and
specifictypes ofcancer (2,3). Several ofthese studieswere
not performed optimally, however, since sources of rare
alleles other than genetic instability were not considered;
these might include ethnic heterogeneity in the case-
control groups or restriction site polymorphisms within
theVNTR region. It maywell be, however, that the H-ras
protooncogene orthesusceptibilitygene(s)isnotessential
in the development ofsome ofthese cancers. In our newly
performedinvestigation ofH-ras VNTR alleles in testicu-
lar cancer patients, we found a high and significantly
increased incidence of rare alleles (Rybert et al., man-
uscript in preparation). Rare VNTR alleles at the H-ras
locus are therefore not unique markers for lung cancer
susceptibility.
It is commonly accepted that cigarette smoking is the
leading risk factor for lung cancer. The hypothesis that
increased cancer susceptibility is related to the presence
of rare ras alleles predicts that the average smoking
history of lung cancer patients with rare alleles may be
different from that of patients without rare alleles.
Unpublished datafrom ourlaboratoryconfirmthispredic-
tion.
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